2016 ACBS Landline-Cellphone Combined Prevalence Tables
BRFSS Asthma Call-back Survey Prevalence TABLE 11b. Estimated percent reporting a medical diagnosis of depression for active1 and inactive2 asthma status among adults3 ever diagnosed with asthma by state/territory – BRFSS Asthma Call-back Survey, United States, 2016.
| State/Territory | Active | Inactive | ||||||
|---|---|---|---|---|---|---|---|---|
| Sample size± |
% | SE§ | 95% CI† | Sample size |
% | SE | 95% CI | |
| Arizona | 356 | 34.3 | 4.5 | (25.5 – 43.1) | 100 | 28.4 | 6.7 | (15.3 – 41.5) |
| California | 263 | 41.6 | 4.1 | (33.6 – 49.6) | 104 | 24.2 | 5.1 | (14.2 – 34.2) |
| Connecticut | 311 | 30.4 | 4.1 | (22.4 – 38.4) | 89 | 34.8 | 9.6 | (16.0 – 53.6) |
| Florida | 973 | 42.6 | 3.6 | (35.5 – 49.7) | 282 | 37.6 | 6.8 | (24.3 – 50.9) |
| Georgia | 156 | 29.3 | 5.1 | (19.3 – 39.3) | 59 | N/A | N/A | (N/A – N/A) |
| Hawaii | 245 | 24.9 | 4.1 | (16.9 – 32.9) | 113 | N/A | N/A | (N/A – N/A) |
| Illinois | 174 | 39.1 | 5.3 | (28.7 – 49.5) | 55 | 37.0 | 8.8 | (19.8 – 54.2) |
| Indiana | 467 | 41.6 | 3.6 | (34.5 – 48.7) | 86 | 35.6 | 8.1 | (19.7 – 51.5) |
| Iowa | 188 | 48.0 | 5.6 | (37.0 – 59.0) | 61 | N/A | N/A | (N/A – N/A) |
| Kansas | 393 | 38.6 | 3.6 | (31.5 – 45.7) | 115 | 31.8 | 6.2 | (19.6 – 44.0) |
| Maine | 578 | 41.6 | 3.3 | (35.1 – 48.1) | 156 | 28.9 | 5.7 | (17.7 – 40.1) |
| Massachusetts | 217 | 37.0 | 4.7 | (27.8 – 46.2) | 49 | 39.1 | 10.0 | (19.5 – 58.7) |
| Michigan | 662 | 42.1 | 2.6 | (37.0 – 47.2) | 176 | 33.4 | 4.6 | (24.4 – 42.4) |
| Minnesota | 609 | 39.9 | 2.5 | (35.0 – 44.8) | 157 | 25.0 | 3.9 | (17.4 – 32.6) |
| Missouri | 278 | 55.9 | 5.4 | (45.3 – 66.5) | 55 | 39.3 | 10.1 | (19.5 – 59.1) |
| Montana | 196 | 41.2 | 5.9 | (29.6 – 52.8) | 65 | 33.4 | 8.8 | (16.2 – 50.6) |
| Nebraska | 469 | 40.4 | 4.6 | (31.4 – 49.4) | 149 | 29.8 | 6.9 | (16.3 – 43.3) |
| Nevada | 158 | 57.2 | 6.3 | (44.9 – 69.5) | 47 | N/A | N/A | (N/A – N/A) |
| New Hampshire | 221 | 37.8 | 4.9 | (28.2 – 47.4) | 64 | 43.8 | 9.2 | (25.8 – 61.8) |
| New Jersey | 287 | 31.1 | 4.6 | (22.1 – 40.1) | 68 | N/A | N/A | (N/A – N/A) |
| New Mexico | 209 | 38.1 | 5.2 | (27.9 – 48.3) | 59 | N/A | N/A | (N/A – N/A) |
| New York | 456 | 28.7 | 4.3 | (20.3 – 37.1) | 123 | N/A | N/A | (N/A – N/A) |
| Ohio | 450 | 39.7 | 3.7 | (32.4 – 47.0) | 124 | 29.2 | 7.1 | (15.3 – 43.1) |
| Oklahoma | 154 | 36.2 | 5.8 | (24.8 – 47.6) | 45 | N/A | N/A | (N/A – N/A) |
| Oregon | 165 | 54.9 | 4.5 | (46.1 – 63.7) | 65 | 21.7 | 5.7 | (10.5 – 32.9) |
| Pennsylvania | 261 | 43.3 | 4.5 | (34.5 – 52.1) | 77 | 22.7 | 6.0 | (10.9 – 34.5) |
| Rhode Island | 188 | 45.1 | 6.1 | (33.1 – 57.1) | 47 | N/A | N/A | (N/A – N/A) |
| Texas | 373 | 45.2 | 5.2 | (35.0 – 55.4) | 121 | 36.9 | 8.6 | (20.0 – 53.8) |
| Utah | 338 | 42.4 | 3.9 | (34.8 – 50.0) | 129 | 35.8 | 6.6 | (22.9 – 48.7) |
| Vermont | 246 | 41.5 | 4.5 | (32.7 – 50.3) | 76 | 26.6 | 6.3 | (14.3 – 38.9) |
| Wisconsin | 220 | 40.8 | 4.9 | (31.2 – 50.4) | 59 | N/A | N/A | (N/A – N/A) |
| Puerto Rico | 322 | 37.7 | 3.8 | (30.3 – 45.1) | 97 | 37.1 | 6.9 | (23.6 – 50.6) |
| 32 states / area | 10,583 | 39.7 | 1.1 | (37.5 – 41.9) | 3,072 | 28.8 | 1.7 | (25.5 – 32.1) |
| Median | 40.6 | 33.4 | ||||||
| Range | 24.9-57.2 | 21.7-43.8 | ||||||
1 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
2 Reported none of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
3 Aged ≥ 18 years
± Landline and cell phone combined sample size excludes “DK/Refused”
§ Standard error
† Confidence interval
N/A: Estimate not available (N/A) if the unweighted sample size for the denominator was < 50 or if the relative standard error was > 0.30
Link for Summary Data Quality Report: https://www.cdc.gov/brfss/acbs/2016/pdf/sdq_report_acbs_16-508.pdfpdf icon
Page last reviewed: February 19, 2020